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Abstract Abnormalities of the arterial valve leaflets, predominantly bicuspid aortic valve, are the
commonest congenital malformations. Although many studies have investigated the development
of the arterial valves, it has been assumed that, as with the atrioventricular valves, endocardial to
mesenchymal transition (EndMT) is the predominant mechanism. We show that arterial is distinctly
different from atrioventricular valve formation. Whilst the four septal valve leaflets are dominated
by NCC and EndMT-derived cells, the intercalated leaflets differentiate directly from Tnnt2-Cre+/
Isl1+ progenitors in the outflow wall, via a Notch-Jag dependent mechanism. Further, when this
novel group of progenitors are disrupted, development of the intercalated leaflets is disrupted,
resulting in leaflet dysplasia and bicuspid valves without raphe, most commonly affecting the aortic
valve. This study thus overturns the dogma that heart valves are formed principally by EndMT,
identifies a new source of valve interstitial cells, and provides a novel mechanism for causation of
bicuspid aortic valves without raphe.
DOI: https://doi.org/10.7554/eLife.34110.001
Introduction
Bicuspid aortic valve (BAV) is the commonest congenital cardiac malformation in man (Hoffman and
Kaplan, 2002). Together with stenosis of the aortic and pulmonary valves, BAV commonly accompa-
nies other congenital cardiovascular malformations, for example, ventricular septal defects, double
outlet right ventricle, hypoplastic left heart syndrome and aortic coarctation (Siu and Silversides,
2010). BAV is also associated with late onset aortopathy (Tadros et al., 2009). These associations
may reflect common developmental origins and/or abnormal haemodynamic forces, but little is
known specifically about arterial (semilunar) valve development and mechanisms have been extrapo-
lated from tricuspid and mitral (atrioventricular) valve development (de Vlaming et al., 2012). Simi-
larly, the pathogenesis of stenotic, dysplastic or bicuspid arterial valves remains obscure, although
fusion of adjacent leaflets in fetal life, resulting in the presence of a raphe, is presumed to cause
many cases of BAV.
Over the past 20 years we have developed a good understanding of how the outflow tract devel-
ops. Cells derived from the second heart field (SHF) make the major contribution to the outflow tract
walls, forming myocardium in the proximal ventricular part, smooth muscle cells in the distal arterial
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walls, and also the inner endocardial lining (Kelly et al., 2014). In the early unseptated outflow tract,
peristaltic contraction propels blood forward and retrograde flow is prevented by occlusion of the
heart tube lumen by voluminous cardiac jelly interposed between endothelium and contracting myo-
cardium (Nomura-Kitabayashi et al., 2009). As the outflow tract lengthens, the cardiac jelly
becomes localised to discrete areas, endocardial cushions, which are the anlagen of the mature valve
leaflets (de Vlaming et al., 2012; Phillips et al., 2013). These initially acellular endocardial cushions
become populated with mesenchymal cells that give rise to the valve interstitial cells. A major source
of cells in both atrioventricular and arterial valves is epithelial or endothelial to mesenchymal trans-
formation (EMT or EndMT; [Markwald et al., 1977; Markwald et al., 1978; de Vlaming et al.,
2012]). In addition, the main outflow tract cushions, that fuse to separate aortic and pulmonary
blood flow and also give rise to the arterial valve leaflets, receive a major contribution of neural crest
cells (NCC) that have migrated through the pharyngeal arches (Kirby et al., 1983; Waldo et al.,
1999; Jiang et al., 2000; Jain et al., 2011; Phillips et al., 2013). In contrast few NCC are seen in
the atrioventricular valves. Smaller swellings located between the main superior and inferior outflow
tract cushions, commonly called intercalated cushions (IC), give rise to the remaining two leaflets
(Kramer, 1942; Anderson et al., 2012; Sizarov et al., 2012; Yang et al., 2013). We have previously
shown that NCC are essential for positioning the main outflow tract endocardial cushions and pat-
terning the arterial valve leaflets, but make only a minor contribution to these IC (Phillips et al.,
2013). More recently, we have also shown that the arterial roots (Figure 1A) that connect the ven-
tricles with the great arteries and house the arterial valves, have a complex origin from both SHF-
derived cells and NCC (Richardson et al., 2018). However, the contribution of each lineage to the
different valve leaflet primordia, and how these relationships affect normal and abnormal leaflet pat-
terning including BAV, remains obscure.
This study demonstrates how the arterial valve leaflets form and defines the origins of the cells
that populate these leaflets. We show that despite the mature arterial valve leaflets appearing indis-
tinguishable, the IC have an entirely distinct origin and underpinning developmental mechanisms
from the major cushions, originating from a novel, direct SHF contribution that is independent of
endMT.
Results
The intercalated cushions are morphologically distinct from the main
outflow cushions
Although the presence of the IC and their participation in arterial valve leaflet development is well-
recognised (Kramer, 1942) (Figure 1B), their origin and composition have not been established. We
therefore analysed their development from mouse embryonic day (E)9.5 and human Carnegie stage
(CS)14. At E9.5, the outflow of the heart consists of a simple tube with an outer myocardial wall, an
inner layer of endocardium and an intervening acellular space filled with cardiac jelly. There was no
evidence of discrete main or intercalated cushions (Figure 1C). By E10.5 the IC were first seen as
anterior and posterior thickenings of the outflow tract outer wall, bulging into localised expansions
of cardiac jelly heralding the main outflow tract cushions (Figure 1D and Figure 1—figure supple-
ment 1). The IC were obvious at E11.5 as compact swellings within the distal outflow tract wall
(Figure 1E) whilst rotation of the outflow tract (Bajolle et al., 2006) placed the aortic IC to the right
and the pulmonary IC to the left. By E12.5, all six primordia of the forming aortic and pulmonary
valve leaflets appeared morphologically similar, although packing of cells in the forming IC appeared
more dense (Figure 1F). At E13.5 and E15.5 the leaflets were indistinguishable from each other
using standard histological staining (Figure 1G,H). These observations were confirmed in human
embryos at equivalent developmental stages (Figure 1I–L).
Although of similar appearance, the pulmonary IC became evident earlier in development and
was more discrete than the aortic IC at E10.5-E11.5. Moreover, the two IC were positioned at differ-
ent levels within the outflow reflecting the orientations of the adult valve structures. Thus, the pul-
monary IC sits more distally by E11.5 and is surrounded laterally by a cuff of outflow tract
myocardium (Figure 1M,P,R), whereas the larger aortic IC only has proximal contact with myocar-
dium (Figure 1N,Q,R). Importantly, both IC have distal continuity with undifferentiated (non-myocar-
dial) outflow tract wall (Figure 1O,Q and Figure 1—figure supplement 1).
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Figure 1. IC have a different morphology to the main outflow cushions during development. All sections, except P,Q are taken in a frontal orientation.
Arrows point to the IC or the IC-derived leaflet primordia, depending on stage. Images are typical examples from a minimum of n = 3 at each stage.
(A) Diagram of the aortic root showing the semilunar attachment pattern of the arterial valve leaflets. The colours reflect the tissue composition of the
root (green = myocardium, blue = smooth muscle cells, yellow = mural fibrous tissue, purple = valvular fibrous tissue). (B) Cartoon (based on
[Kramer, 1942]) illustrating how fusion of the main outflow cushions together with growth of the IC produces the three arterial valve primordia. (C–H)
At E9.5 (C), the outflow tract is a simple tube with an outer myocardium and inner endocardium, but with few cells in between. The arrow points to the
region where the IC will appear, but there is no evidence of wall thickening at this stage. By E10.5 (D), cells are seen in the cardiac jelly and IC appear
as bulges in the outflow wall (arrows). At E11.5 (E), the IC (arrows) have expanded but are significantly smaller than the main outflow cushions. The
posterior valve primordia (arrows) are well developed and appear similar to the right and left valve primordia at E12.5-E13.5 (F,G), although the cells
appear more densely packed. By E15.5 (H), the valve sinuses have formed and the leaflets are apparent. (I–L) IC are also apparent in stage matched
(CS14-16) human embryos and have a similar morphology to those seen in mouse at CS21. (M–Q) The pulmonary IC (labelled red by Isl1 in P) is
encased by a thin layer of cTnI-expressing (green) myocardium (arrows in M,P), whereas the aortic IC is not (N,Q). At E11.5, the IC are in continuity with
Isl1-expressing cells in the pharyngeal region (red in P,Q). (O,R) At E11.5 (O), 3D reconstruction (modified from those first presented in
[Anderson et al., 2012]) shows the non-myocardial component of the outflow (dark green) extends into the myocardial component (light green). The
IC form within these extensions (arrows). At E12.5, the pulmonary IC (brown, see arrow) is found more distally than the aortic IC (green, see arrow). AMC
– aortic mitral continuity; Ao – aorta; AV – aortic valve; IC – intercalated cushion; IVS – interventricular triangle; LCA – left coronary artery; LV – left
ventricular myocardium; NC – non coronary; P or Pul – pulmonary trunk; PV – pulmonary valve; RCA – right coronary artery; RDL – right-left interleaflet
triangle; RDN – right - non-coronary interleaflet triangle; S-T – sino-tubular. Scale bar: C-E,I-K,P,Q = 100 mm, F,G = 150 mm, H,L = 200 mm.
DOI: https://doi.org/10.7554/eLife.34110.002
Figure 1 continued on next page
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IC undergo late differentiation to become valve primordia
These initial observations suggested that the origins of the IC are developmentally distinct from the
main outflow cushions. To evaluate the tissue characteristics of these primordia we examined the
expression of chondroitin sulphate, a component of both the extracellular matrix (ECM) of the car-
diac jelly and valve primordia (Markwald et al., 1978), using CS56 antibody. We also investigated
expression of cardiac troponin I (cTnI), a myocardial specific protein, to elucidate the relationships of
the IC with the myocardial wall. At E10.5 cardiac jelly, labelled by CS56 antibody, was found in a cir-
cumferential layer between the myocardium and endocardium, with laterally located accumulations
of cells that prefigured the main cushions (Figure 2A). Although the IC within the wall were not
labelled by CS56, a thin layer of CS56-expressing cardiac jelly overlaid their luminal surface
(Figure 2D,G). The outflow tract wall labelled with cTnI antibody, but despite continuity with this
wall, the IC did not express cTnI. At E11.5, the main outflow tract cushions contained many cells and
continued to strongly label with CS56 antibody (Figure 2B). In contrast, although the IC had
expanded, they remained devoid of labelling for cTnI or for CS56, except for the thin layer of adlu-
minal cardiac jelly (arrowheads in Figure 2E). When examined at E12.5, the main cushions and the
IC labelled with the CS56 antibody (Figure 2C,F,I). To further understand the differentiation of these
IC we examined them for the expression of proteins relevant to endocardial cushion differentiation.
Versican is a chondroitin sulphate proteoglycan that is expressed early and plays essential roles in
cushion formation (Henderson and Copp, 1998; Mjaatvedt et al., 1998). At E10.5, Versican was
only detected in the cardiac jelly of the main septal cushions and the thin layer of cardiac jelly overly-
ing the IC. However, at E11.5, prior to expression of CS56, and also at E12.5, Versican was
expressed within the bulk of the IC (Figure 2J–O). At E10.5 Sox9, a transcription factor necessary
for the formation of endocardial cushions and maintained in mature valve leaflets (Akiyama et al.,
2004; Richardson et al., 2018), was abundantly expressed in the circumferential layer of cardiac jelly
where the main cushions form, but only in the area immediately adjacent to the endothelium overly-
ing the IC that was labelled by CS56 (Figure 2P,S – compare to 2 D,G); there was no Sox9 in the
main part of the IC at this stage. At E11.5 Sox9 was also expressed throughout the IC and this was
maintained at E12.5 (Figure 2Q,R,T,U). Taken together, these findings indicate that at early stages
the IC are overlaid by a layer of cardiac jelly but are not endocardial cushions in the classical sense.
However, as they mature they express markers of valve interstitial cells. In view of this we henceforth
refer to them in this manuscript as intercalated valve swellings (ICVS) as in Kramer’s original descrip-
tion (Kramer, 1942).
Undifferentiated SHF cells directly contribute to the ICVS
We have previously shown that whilst NCC and EndMT-derived cells (EDC) make a major contribu-
tion to valve primordia derived from the main outflow cushions at E11.5 and E12.5, they make only a
minor contribution to the laterally-placed IC (Phillips et al., 2013). These patterns are highly repro-
ducible (n > 10). More thorough analysis showed that the proportion of Wnt1-Cre+ lineage cells was
significantly different between the valve primordia, X2 (df5, N = 6842)=959.4, p<0.0001 (Figure 3—
source data 1). Pairwise chi-squared comparison, with Bonferroni correction for multiple testing,
confirmed that the aortic posterior (non-coronary) and anterior pulmonary primordium were statisti-
cally different from all other primordia (for each, p<0.0002). Whereas the left aortic primordium was
statistically different from the remaining primordia (p<0.02), the aortic right, pulmonary left and pul-
monary right were not significantly different with respect to the number of Wnt1-Cre+ lineage cells
they contained. Chi squared analysis showed that the proportion of Tek-Cre lineage cells between
the different arterial valve primordia were significantly different, X2 (df5, N = 7389)=782.3, p<0.0001
(Figure 3—source data 1). Pairwise Chi-squared comparison between the primordia, with Bonfer-
roni correction for multiple testing, confirmed that the aortic non-coronary, the pulmonary right and
the pulmonary anterior were not statistically different in the proportion of Tek-Cre+ lineage cells
Figure 1 continued
The following figure supplement is available for figure 1:
Figure supplement 1. Histological appearance of the IC as they first form.
DOI: https://doi.org/10.7554/eLife.34110.003
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they contained. However, all the remaining primordia were statistically different (p<0.0002). Thus,
these data showed that there were marked variations in the NCC and EDC contributing to each leaf-
let and confirmed that there were insufficient Wnt1-Cre+ and Tek-Cre+ lineage traced cells to
account for all the cells present in these valve primordia (Figure 3A–F and Figure 3—figure supple-
ment 1). We therefore looked for alternative sources to explain the origins of the remaining cells in
the developing arterial valve leaflets. As the parietal valves of the atrioventricular valves are known
to contain epicardially-derived cells (EPDC; [Gittenberger-de Groot et al., 1998; Wessels et al.,
2012]). We asked whether EPDC could contribute to the ICVS or other outflow cushions. To test
this, we performed tamoxifen induction in Wt1-Cre-ERT2 mice starting at E9.5. Analysis at E12.5
Figure 2. IC are molecularly distinct from the main outflow cushions. In each case, arrows mark the IC. * mark the main outflow cushions. In D-U the
myocardium is labelled with cTnI (green). Images are typical examples from a minimum of n = 3 at each stage. (A–C) The cardiac jelly of the main
outflow cushions contain chondroitin sulphate molecules, recognised by the antibody CS56, from E10.5 to E12.5, whereas these are only abundant in
the IC at E12.5. (D–I) Higher power of CS56 immunoreactivity shows that although the bulk of the IC stain with neither cTnI nor CS56 at E10.5-E11.5
(arrows), they are overlaid by a layer of CS56-expressing material (arrowheads in D,E,G) that is continuity with the main outflow cushions. By E12.5, the
majority of the leaflet primordium is labelled by CS56. (J–O) Versican is expressed in the cardiac jelly of the main cushions at E10.5 and the adluminal
region overlying the IC (arrowhead in J,M). Versican is not found in the bulk of the IC at E10.5, (J,M) but is expressed more broadly in the IC at E11.5
and E12.5. Notably, versican is missing from the centre part of both the aortic and pulmonary IC at E12.5 (arrows in L,O). (P–U) Sox9 labels only the
layer overlying the IC at E10.5 (arrowheads in P,S) but is expressed throughout the ICVS by E11.5 and at E12.5. Scale bar: A = 90 mm, B,F,I,L,O,R,
U = 120 mm, C = 250 mm, D,G,J,M,P,S = 50 mm, E,H,K,N,Q,T = 70 mm.
DOI: https://doi.org/10.7554/eLife.34110.004
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Figure 3. The ICVS are formed from undifferentiated SHF-derived cells that are labelled by TnnT2-Cre. All sections are frontal unless otherwise stated.
Arrows mark the ICVS. * mark the main outflow cushions. Images are typical examples from a minimum of n = 3 at each stage. (A–F) NCC labelled by
Wnt1-Cre (A,B) make a significant contribution to the main outflow cushions and right and left valve primordia at E11.5 and E12.5, but make only a
minor contribution to the ICVS and anterior leaflets (arrows). Tek-Cre labels cells in the endocardium (arrow in C), but few cells in either the main
cushions or ICVS at E11.5 (C), although they are abundant in the left and right leaflets by E12.5 (D). Quantification of cells at E12.5 (E,F) confirms these
observations and reveals that there are a number of cells in the leaflets, particularly the anterior and posterior derived from the ICVS, that are not
labelled by NCC or EDC (data reanalysed from [Phillips et al., 2013]). (G–J) Wt1-ERT-Cre labels the epicardium (arrowheads in G) but not cells in the
ICVS (arrows in G). The ICVS are labelled by Mef2c-AHF-Cre at E11.5 and E12.5 (H,I), as are the main cushions and the left and right leaflet primordia.
Quantification of these cells (J) shows that the Mef2c-AHF-Cre-expressing population is the major contributor to the leaflet primordia. (K–N) Cells
expressing Tnnt2-Cre label the cells in the ICVS at E11.5 (arrows in K,L) and the posterior valve leaflet primordia at E12.5 (M). A few labelled cells are
also seen in the left and right primordia. (N) Tnnt2-Cre labels cells in all leaflets (arrows) of the aortic valve at P2, although it is more abundant in the
posterior leaflet. Tnnt2-Cre also labels the walls of the aortic sinuses that are composed of SMC (arrowhead). (O,P) Antibodies specific for cardiac
troponin-T (O), cTnI (green in P) and aSMA (red in P) label the outflow wall but not the ICVS at E11.5. (Q–V) At E9.5, a Tnnt2-Cre-positive, but cTnT-
negative region (arrows in Q-S) is apparent in the distal outflow wall. A similar region can be seen in transverse sections at E10.5 (arrows in T-V). N.B.
mTmG was used as the reporter line in Q-S so the GFP staining appears membrane associated in these sections. (W–Y) Some of the cells in the ICVS
Figure 3 continued on next page
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showed that although the epicardium itself was strongly labelled, there was no contribution of EPDC
into the forming arterial valve leaflets (Figure 3G).
The dorsal pericardial wall and the pharyngeal mesoderm are composed of SHF cells that directly
generate the outflow tract myocardium, much of the smooth muscle and fibrous tissue in the proxi-
mal and distal outflow vessel walls, and also the endocardium that lines these structures
(Waldo et al., 2005; Harmon and Nakano, 2013; Verzi et al., 2005; Richardson et al., 2018).
Moreover, the SHF through endothelial EndMT, indirectly populates the outflow tract cushions
(Verzi et al., 2005); Figure 3—figure supplement 1). We wondered whether SHF progenitors might
contribute to the ICVS, over and above those provided by EndMT. By lineage tracing using Mef2c-
AHF-Cre, it was possible to identify all SHF-derived cells adding into the valve anlagen, either
directly or through EndMT. Analysis at E11.5 and E12.5 revealed that cells derived from the Mef2c-
AHF-Cre+ SHF make a major and highly reproducible contribution to all of the arterial valve leaflet
primordia, including the ICVS (Figure 3H–J). Chi squared analysis following quantification of the
Mef2c-AHF-Cre+ lineage cells in the E12.5 leaflet primordia showed that the proportion of these
cells were significantly different between the different arterial valve primordia, X2 (df5, N = 7435)
=748.2, p<0.0001 (Figure 3—source data 1). Pairwise Chi-squared comparison between the primor-
dia, with Bonferroni correction for multiple testing, confirmed that the aortic anterior (non-coronary)
primordium was statistically different from all other primordia (p<0.0002), as was the pulmonary pos-
terior primordium (p<0.0002). Moreover, whilst the right pulmonary primordium was statistically dif-
ferent from the remaining primordia (p<0.02); the aortic left, aortic right and pulmonary left were
not significantly different. Importantly, our analysis demonstrated that the numbers and distribution
of Mef2c-AHF-Cre+ lineage cells in the ICVS and in both the main cushions were complementary to
the Wnt1-Cre+ lineage (compare Figure 3J with 3E) and were sufficient to explain the presence of
all cells.
Origin of ICVS directly from SHF progenitors in the outflow wall
A possible source of the SHF-derived cells within the ICVS was trans-differentiation of outflow tract
myocardium. To explore this, we carried out lineage tracing using the cardiomyocyte-specific Tropo-
nin T-Cre (cTnT; Tnnt2-Cre) line. Analyses of the ICVS, both during formation at E11.5 and when
they resemble the main cushions at E12.5, showed that the ICVS and the adjacent outflow tract wall
was indeed composed of cells demonstrating Tnnt2-Cre+ lineage (Figure 3K–M). In addition to this
major contribution of Tnnt2-Cre+ lineage cells to the ICVS at these stages, a few labelled cells were
also found in the right and left leaflets derived from the main septal cushions, located within the
outer parts of the leaflets, close to the myocardial wall. Examination of Tnnt2-Cre;eYFP embryos at
later stages of development showed that the Tnnt2-Cre+ lineage cells were found in all three arterial
valves throughout gestation and postnatally, although the majority were found in the anterior/poste-
rior leaflets; these data indicate that Tnnt2-Cre+ lineage cells make a permanent contribution to the
valve leaflets (Figure 3N). However, as shown earlier, the E11.5 ICVS did not contain differentiated
cardiomyocytes, thus did not express cTnT, cTnI, nor aSMA, a smooth muscle cell (SMC) marker
Figure 3 continued
label co-express (yellow; arrows) Isl1 and Sox9 antibody at E11.5. Scale bar: A-D,H,K,L,M = 100 mm, G,I = 150 mm, N = 400 mm, O,p=60 mm, Q-V = 50
mm, W-Y = 40 mm.
DOI: https://doi.org/10.7554/eLife.34110.005
The following source data and figure supplements are available for figure 3:
Source data 1. Raw data from lineage tracing for Wnt1-Cre+, Tek2-Cre+ and Mef2c-AHF-Cre+ cells in E12.5 valve leaflets.
DOI: https://doi.org/10.7554/eLife.34110.010
Figure supplement 1. Lineage of cells in the main outflow cushions.
DOI: https://doi.org/10.7554/eLife.34110.006
Figure supplement 2. Confirmation of timing of Cre expression.
DOI: https://doi.org/10.7554/eLife.34110.007
Figure supplement 3. Tnnt2-Creexpression in SMC.
DOI: https://doi.org/10.7554/eLife.34110.008
Figure supplement 4. Persistance of Isl1 expression in ICVS.
DOI: https://doi.org/10.7554/eLife.34110.009
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(Figure 3O,P). As the Cre lineage tracing indicated cells that not only currently expressed cTnT, but
also those that were descended from cells that previously expressed cTnT, we used antibodies
directed against cTnT/cTnI together with Tnnt2-Cre lineage tracing at earlier stages of development,
to establish whether cells in the ICVS ever expressed these markers. Despite their Tnnt2-Cre+ lineage
labelling, the ICVS did not label with antibodies to cTnT nor cTnI at any stage of development. At
E9.75, before the ICVS could be seen in the distal outflow, a region of Tnnt2-Cre+;cTnT- labelling
was seen, likely indicating where the ICVS would develop (Figure 3Q–S). Similarly, At E10.5 the
most distal outflow wall was Tnnt2-Cre-expressing, but did not label with cTnT antibody (Figure 3T–
V). Thus, our data argue against trans-differentiation of ICVS cells from cardiomyocytes. To clarify
the timing of Cre expression driven by the Tnnt2 promoter activity in the ICVS, we used an anti-Cre
antibody. By examining embryos at E10.5-E12.5 we showed that at E10.5 Cre protein was found in
the forming ICVS and in the myocardial wall. However, by E11.5, and continuing at E12.5, Cre pro-
tein was absent from the ICVS, although still maintained in the myocardial walls (Figure 3—figure
supplement 2). Taken together these data indicate that Tnnt2-Cre activation in the forming ICVS
occurred prior to full differentiation to cardiomyocytes and taking into account perdurance of Cre
protein, is likely to occur before E10.5. Interestingly, Tnnt2-Cre+ lineage cells were also observed in
SMC within the arterial wall later in development (Figure 3N and (Figure 3—figure supplement 3).
A key question is whether these ICVS cells originate directly from undifferentiated SHF cells. As
they remain in continuity with the dorsal pericardial wall, we wondered if they might also have
retained an undifferentiated state. Islet 1 (Isl1) is a specific marker of multipotent SHF progenitors
that are yet to differentiate into a broad range of cell types including cardiomyocytes (Cai et al.,
2003). At E11.5 the ICVS were clearly delineated within the distal outflow wall by Isl1 antibody
(Figure 3W,Y and Figure 3—figure supplement 4); co-localisation studies showed that some of the
cells also expressed Sox9 and thus were directly differentiating into valve interstitial cells
(Figure 3W–Y and Figure 3—figure supplement 4). By E12.5, Isl1 expression had essentially disap-
peared from the outflow tract, although persisting low level Isl1 expression was noted in a few cells
in the ICVS (Figure 3—figure supplement 4). Thus, the cells within the ICVS, although of Tnnt2-Cre
+ lineage, are formed from Mef2c-AHF-Cre-expressing SHF progenitor cells that maintain expres-
sion of Isl1 for longer than the surrounding cells, suggesting they differentiate later. Co-expression
of reducing Isl1 protein levels but increasing Sox9 protein levels, in the setting of absence of protein
for differentiated cardiomyocyte markers, supports direct derivation of valve precursors from SHF,
rather than trans-differentiation from myocardial wall.
ICVS derive from SHF epithelium, but not through EMT
We have previously shown how SHF progenitor cells from the dorsal pericardial wall add to the elon-
gating outflow tract at E9.0-E9.5 (Ramsbottom et al., 2014) and form the myocardium of the out-
flow tract. As they do so they initially up-regulate E-cadherin and show marked cellular polarisation.
As addition continues, they lose their epithelial phenotype, down-regulate Isl1, and then express
markers of differentiated cardiomyocytes in the segment of outflow tract we termed the transition
zone (Ramsbottom et al., 2014). E-cadherin was expressed throughout the distal outflow wall
including the forming ICVS at E10.5, (Figure 4A–C) but was not expressed in the main cushions. By
E11.5 levels of E-cadherin expression were reduced in the ICVS (Figure 4D–F) and by E12.5, E-cad-
herin was absent (Figure 4G–I). This was paralleled by b-catenin expression, which also labels epithe-
lial cells, (Figure 4J), but was entirely different from N-cadherin and fibroblast specific protein 1
(Fsp1) immuno labelling, both of which are markers of mesenchymal cells. Specifically, neither N-cad-
herin nor Fsp1 were expressed in the ICVS at any stage of development (Figure 4K,L), indicating
that the ICVS do not contain typical mesenchymal cells. Interestingly, collagen I and elastin, both
ECM proteins normally seen surrounding SMC in the tunica media of blood vessels and also found in
mature valve leaflets (Hinton and Yutzey, 2011), were transiently expressed only in the forming
ICVS but not in the surrounding walls or main cushions at E11.5 (Figure 4M–O and Figure 4—figure
supplement 1). These data suggest that at E11.5 and E12.5, the ICVS cells express different markers
to the cells that make up the right and left leaflets and the adjacent myocardial wall. In contrast, lam-
inin, an ECM protein highly expressed in the basement membrane of epithelia, was highly expressed
in the ICVS at E10.5 but was down-regulated by E11.5-E12.5 (Figure 4P–R). Together, these data
suggest that epithelial SHF progenitors in the ICVS differentiate to valve interstitial cells, but not via
an undifferentiated mesenchymal intermediate. To rule out EMT as a mechanism, we evaluated
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Figure 4. The ICVS transition from epithelium to mesenchyme, but not by a typical process of EMT. Unless otherwise stated, the aortic IC is shown.
Arrows point to the ICVS or posterior valve primordium in each case. * mark the main outflow cushions. Images are typical examples from a minimum
of n = 3 at each stage. (A–C) The ICVS express E-cadherin (green) at E10.5 (A,B), as does the surrounding myocardial outflow wall (labelled red by cTnI),
although the main cushions do not. (D–I) E-cadherin is downregulated in the ICVS at E11.5 (D,E), and is no-longer expressed by E12.5 (G,H). (J–L) b-
catenin is expressed in the ICVS and the surrounding wall at E11.5 (J), but neither N-cadherin nor Fsp1 (K,L) are found in the ICVS at this stage. (M–O)
Collagen-I is transiently up-regulated specifically in the ICVS but not the main cushions at E11.5, but resembles the main leaflet primordia with little if
any expression at E10.5 and E12.5. (P–R) Laminin is also transiently expressed in the ICVS at E10.5, but is downregulated and lost from the valve
primordia by E12.5. (S–V) Neither Slug nor Snail are expressed in the ICVS (arrows in S,U,V) at E10.5–11.5, although they are both abundant in the main
cushions (* in T,U,V). Scale bar: A-I,M,N,p=60 mm, J-L,O,Q-V = 100 mm.
DOI: https://doi.org/10.7554/eLife.34110.011
The following figure supplement is available for figure 4:
Figure supplement 1. ICVS do not express classical mesenchymal markers as they form.
DOI: https://doi.org/10.7554/eLife.34110.012
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expression of Slug and Snail, key regulators of EMT, by in-situ hybridisation, focussing on E10.5 and
E11.5 embryos, as by E11.5 Sox9 is found in the ICVS (Figure 2Q,T) and thus the valve cell precur-
sors have formed. Notably, there was no expression of transcripts for either Slug or Snail within the
ICVS at E10.5 or E11.5, although both were abundantly expressed in both the endothelium and
newly formed mesenchyme of the main outflow cushions (Figure 4S–V and Figure 4—figure supple-
ment 1). Thus, although the cells of the ICVS change from an epithelial to valve interstitial cell phe-
notype, this does not occur via classical EMT.
Jagged-Notch signalling is active and required for ICVS development
Notch1 signalling plays an essential role in formation of the atrioventricular and main outflow cush-
ions in the developing heart. It is involved, together with its ligand Dll4, in EndMT (Luna-
Zurita et al., 2010), but also acts later during valve remodelling with an alternative ligand, Jag1
(MacGrogan et al., 2016). Moreover, NOTCH1 mutations have been implicated in BAV (Garg et al.,
2005). To identify the molecular mechanism underpinning formation of the ICVS we first asked
whether there is Notch1 signalling activity in the ICVS. Immunolabelling confirmed that the active
Notch1 receptor (Notch1 intracellular domain or N1ICD) was present in the non-myocardial walls of
the aortic sac, the distal outflow and the endocardium. It was specifically expressed in cells within
the ICVS at E10.5 although by E11.5 only a few cells in the cardiac jelly overlying the core of the
ICVS continued to express nuclear N1ICD (Figure 5A,E,I), indicating a temporal window of Notch1
signalling activity. Immuno staining for Notch2 (using an antibody that recognised the uncleaved
form of the protein) was also expressed in the membranes of cells within the ICVS but not in the
main cushions (Figure 5B,F,J). Dll4 was found in the endocardium with N1ICD, but not in the ICVS
at either E10.5 or E11.5 (Figure 5—figure supplement 1). We also evaluated the expression of both
Jag1 and Jag2 ligands in this region of the heart. Jag1 protein was specifically detected within the
distal outflow wall and in the core of the ICVS at both E10.5 and E11.5 (Figure 5C,G,K). In contrast,
Jag2 was detected only in the inner adluminal region of the ICVS, close to the Notch1ICD-express-
ing endothelial cells (Figure 5D,H,L). On closer examination Notch 2, Jag1 and Jag2 were found at
the membrane of ICVS cells that expressed Isl1 at E10.5 and E11.5 whereas N1ICD was mostly
expressed in the nucleus of Isl1-negative cells (Figure 5Q-AB and Figure 5—figure supplement 2).
By E12.5, neither N1ICD or Notch2, nor Jag1 or Jag2, were expressed in the interstitial cells within
the ICVS (Figure 5M–P), although both N1ICD and Notch2 were expressed in the valve endothe-
lium. Thus, it appeared that Notch signalling was temporally and spatially associated with differentia-
tion of ICVS SHF-derived cells into valve interstitial cells.
To test the requirement for Jag-Notch signalling in formation of the ICVS, we deleted Jag1 gene
expression using Tnnt2-Cre and examined the arterial valve appearances at E16.5. No Jag1f/f;Tnnt2-
Cre (0/11) or Jag2f/f;Tnnt2-Cre (0/2) embryos demonstrated BAV, nor were abnormalities observed
in Tnnt2-Cre-negative embryos (Figure 6A). We therefore wondered if Jag1 and Jag2 might be
compensating for each other in the formation of the ICVS, as has been demonstrated in ventricular
maturation (D’Amato et al., 2016). Jag1f/f, Jag2f/f and Tnnt2-Cre animals were inter-crossed and
the arterial valve phenotype examined in the resulting offspring. In this complex genetic breeding
experiment, BAV was observed in 1/3 Jag1f/+;Jag2f/f;Tnnt2-Cre mutants examined (Figure 6B),
whilst in the absence of both ligands 4/11 Jag1f/f;Jag2f/fcTnnt2-Cre embryos demonstrated BAV
(Figure 6C). Notably, the posterior (non-coronary) leaflet appeared to be missing in each case and
there was no obvious presence of a raphe that would indicate leaflet fusion. One additional Jag1f/f;
Jag2f/f;Tnnt2-Cre embryo had only a rudimentary posterior leaflet (Figure 6D) and a further 4/11
Jag1f/f;Jag2f/f;Tnnt2-Cre embryos had thickened or dysplastic arterial valve leaflets affecting either/
both the aorta and pulmonary valve (Figure 6C). In these latter cases, abnormalities in all three leaf-
lets of the valves were apparent. Thus, 9/11 Jag1f/f;Jag2f/f;Tnnt2-Cre embryos examined had major
abnormalities in the development of the arterial valve leaflets, that affected the anterior/posterior
leaflets that develop from the Tnnt2-Cre+ ICVS. Most (7/9) of these valve defects in the Jag1f/f;
Jag2f/f;Tnnt2-Cre embryos occurred in the context of other cardiac anomalies, most commonly ven-
tricular septal defect or double outlet right ventricle.
Similar abnormalities to those we observed in Jag2f/f;Tnnt2-Cre mutants have previously been
described for the Notch regulator Mib1f/f;Tnnt2-Cre embryos (Captur et al., 2016). We therefore
confirmed these findings, showing absence (1/9) or dysplasia (8/9) of the non-adjacent (non-coro-
nary) leaflet in the mutant embryos at E16.5 (Figure 6E,F). We then examined the formation of the
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Figure 5. Notch signalling is found in the developing ICVS. All sections are frontal unless otherwise stated. Images are typical examples from a
minimum of n = 3 at each stage. In E-AB, arrows point to the ICVS. (A–D) Sagittal sections show that Notch1ICD, Notch2 and Jag1 are abundant in the
distal outflow wall (arrows) at E10.5. Jag2 is only found in the endothelium (arrow in D). (E–L) Notch1ICD, Notch2, Jag1 and Jag2 are found in the
endocardium overlying the main cushions, but not within the cushions themselves at E10.5–11.5. All four localise to the ICVS at E10.5, with Notch1ICD,
Notch2 and Jag1 maintained at E11.5. (M–P) Notch1ICD, Notch2 and Jag1 are found in the valve endothelium at E12.5, but none of these, nor Jag2, is
found in the valve interstitial cells G-AB) Isl1 and Notch1ICD co-localise in the nuclei of only a few cells within the ICVS at E10.5, although Notch2, Jag1
and Jag2 are found in the membrane of Isl1 +nuclei containing cells in the core of the ICVS at this stage. Scale bar: A-D = 360 mm, E-H = 120 mm,
I-L = 150 mm, M-P = 225 mm, Q-AB = 75 mm.
DOI: https://doi.org/10.7554/eLife.34110.013
The following figure supplements are available for figure 5:
Figure supplement 1. Dll4 immuno-reactivity is found in the endocardium from E10.5-E12.5 (arrows).
Figure 5 continued on next page
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Figure 5 continued
DOI: https://doi.org/10.7554/eLife.34110.014
Figure 6. Disruption of Notch signalling results in abnormalities of the posterior (non-coronary) leaflet. Transverse
H and E-stained sections of E16.5 embryos from Jag1f;Jag2f;Tnnt2-Cre litters. Images are typical examples. (A–D)
Whereas the control embryo has three thinned leaflets in its aortic valve (A), the Jag1f/+;Jag2f/f;Tnnt2-Cre and
Jag1f/f;Jag2f/f;Tnnt2-Cre embryo (B,C) have only two thickened leaflets with no leaflet in the posterior position (*).
In the Jag1f/f;Jag2f/f;Tnnt2-Cre embryo (D) a rudimentary posterior leaflet can be seen. The arrows point to the
thickened left leaflet. (E,F) The Mib1f/f;Tnnt2-Cre embryo also has a hypoplastic posterior leaflet and dysplasia of
the other valve leaflets. (G,H) Examination of the forming ICVS at E11.5 shows a reduction in the number of
Sox9+/Isl1 +cells in the Mib1f/f;Tnnt2-Cre embryo compared to its control littermate. Images are typical examples
from a minimum of n = 3 at each stage. A - anterior, L – left, R – right. Scale bar: A-F = 200 mm, G,H = 60 mm.
DOI: https://doi.org/10.7554/eLife.34110.016
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ICVS in these mutants at E11.5, showing that in 1/3 of the Mib1f/f;Tnnt2-Cre examined, the ICVS
were poorly formed with fewer Sox9+/Isl1 +cells (Figure 6G,H). This supports the idea that Notch
signalling plays a critical role in the formation of the ICVS.
SHF deficiency leads to ICVS defects and BAV
These data indicate that the SHF addition to the outflow tract wall is required for formation of the
ICVS, which then give rise to the posterior leaflet of the aortic valve and the anterior leaflet of the
pulmonary valve. We wondered if reduction of SHF addition to the ICVS would be sufficient to cre-
ate hypoplastic ICVS and produce BAV. We have previously disrupted SHF addition to the outflow
tract by deleting Vangl2 gene expression from the SHF using Isl1-Cre. This resulted in disruption of
epithelial polarity and premature differentiation of SHF cells within the distal outflow tract of Vangl2;
Isl1-Cre mutants, leading to double outlet right ventricle and ventricular septal defect
(Ramsbottom et al., 2014). At that time, we did not examine the development of the aortic and pul-
monary valves. As the naturally occurring Vangl2 mutant loop-tail, which is fully re-capitulated by
SHF deletion of Vangl2 (Ramsbottom et al., 2014), demonstrates aortic, but not pulmonary, hypo-
plasia (Henderson et al., 2001), we speculated that loss of Vangl2 in the SHF progenitors would dis-
rupt formation of the ICVS, particularly affecting the aortic side of the outflow. Analysis of seven
Vangl2f/f;Isl1-Cre embryos at E15.5 revealed that 57% (4/7) of them had dysplastic leaflets and BAV
without raphe, with absence of the leaflet normally positioned posteriorly (Figure 7A–D and Fig-
ure 7—figure supplement 1). Dysplasia of the pulmonary valve was also observed in these hearts.
Analysis at E10.5 and 11.5 showed that although both the aortic and the pulmonary ICVS were pres-
ent in Vangl2f/f;Isl1-Cre heart, they were misplaced. In 2/6 cases, they were also smaller than
expected (Figure 7E–H). Despite this they demonstrated apparently normal expression of a panel of
markers at E11.5, including Isl1, b-catenin and E-cadherin (Figure 7E–H and Figure 7—figure sup-
plements 1 and 2). However, Notch1ICD and Jag1 were missing or reduced in 2/3 E11.5 Vangl2f/f;
Isl1-Cre hearts examined (Figure 7I–L), suggesting that Notch signalling was disrupted in these
mutants. Moreover, there was abnormal distribution of cTnI-expressing myocardial cells surrounding
the ICVS at E11.5 and E12.5 (arrows in Figure 7—figure supplements 1 and 2). Close examination
suggested that these were within the ICVS/valve primordium and so likely reflect abnormal differen-
tiation or ingrowth of cardiomyocytes rather than detachment of layers of myocardium. Together,
the hypoplastic ICVS and misexpression of cTnI suggest that rather than forming valve interstitial
cells, the ICVS may be mis-specified or prematurely differentiate to myocardium, thus preventing
the formation of a mature leaflet in this position.
DiGeorge syndrome is a chromosomal micro-deletion syndrome with cardiovascular defects, due
to deficiency of the TBX1 gene. Tbx1 null mice replicate the cardiovascular features seen in patients
with DiGeorge syndrome. As the SHF-derived pulmonary myocardium of the outflow tract is defi-
cient in these mice, and absence of the anterior leaflet of the pulmonary valve has also been
reported (The´veniau-Ruissy et al., 2008), we wondered whether these mutants might exhibit hypo-
plasia of the pulmonary ICVS. Analysis of Tbx1 null mice at E15.5 and E12.5 confirmed that the valve
leaflets were markedly abnormal within the unseptated Tbx1-/- outflow tract (Figure 8A,D). Utilising
aSMA and cTnI antibodies, a single ICVS could be seen in the Tbx1-/- outflow tract at E12.5. Looking
earlier, at E11.5, whereas a well-developed aortic ICVS could be seen in Tbx1-/-, it was impossible to
distinguish a discrete pulmonary ICVS, with cTnI and aSMA-expressing cells within the expected
region (Figure 8E–H). Thus, as in Vangl2;Isl1-Cre mutants, the disrupted development of the ICVS
may underpin, at least in part, the arterial valve defects seen in Tbx1 mutant mice.
Discussion
We have shown that the formation of the arterial valves, whilst encompassing some processes that
are similar to the atrioventricular valves, is uniquely different, by virtue of the large influx of NCC
and the dominant role played by the SHF. The central four valve leaflets, formed as the outflow tract
septates, are filled by NCC and SHF cells secondarily derived through endocardium and transformed
into valve interstitial cell precursors by EndMT. In contrast, the intercalated valve structures are not
cardiac jelly-derived endocardial cushions, but instead differentiate directly from (Mef2c-AHF-Cre+;
Tnnt2-Cre+) SHF-derived outflow wall; Figure 9). These cells retain signatures of previous cardiac
troponin promoter activation, although they are not, and never have been, of myocardial phenotype.
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Figure 7. Failure to form the aortic posterior (non-coronary) leaflet in Vangl2f/f;Isl1Cre embryos. Images are typical
examples of a minimum of n = 3. (A–D) Whereas the posterior leaflet (arrow in A) can clearly be seen in the control
embryo at E15.5, this is missing in the Vangl2f/f;Isl1-Cre embryos (arrowhead in C). (E–H) Hypoplastic and
malpositioned ICVS (arrows) can be seen in Vangl2f/f;Isl1-Cre embryos at E11.5. Expression of outflow markers
appears otherwise normal. (I–L) Notch1ICD and Jag1 expression levels are reduced in the ICVS of some Vangl2f/f;
Figure 7 continued on next page
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Figure 7 continued
Isl1-Cre embryos compared to control littermates at E11.5 (arrows), although there is normal expression elsewhere
in the outflow walls. Scale bar: A-D = 120 mm, E-H = 100 mm, I-L = 120 mm.
DOI: https://doi.org/10.7554/eLife.34110.017
The following figure supplements are available for figure 7:
Figure supplement 1. ICVS formation in Vangl2;Isl1-Cre mutants.
DOI: https://doi.org/10.7554/eLife.34110.018
Figure supplement 2. Marker expression in Vangl2;Isl1-Cre mutant ICVS.
DOI: https://doi.org/10.7554/eLife.34110.019
Figure 8. Failure to form the pulmonary anterior leaflet in Tbx1 null embryos. Images are typical examples of a
minimum of n = 3. (A,B) The outflow tract remains unseptated and the valve leaflets are markedly abnormal in the
Tbx1-/- at E15.5. It is not possible at this stage to establish the identity of the leaflets. (C–F) At E12.5, Tbx1+/-
embryos have septated their outflow tract and have three leaflet primordia in both the aorta and pulmonary trunk.
In contrast, the Tbx1-/- littermate has not septated its outflow tract and there is a single ICVS (arrows in D and F).
(G,H) At E11.5, the aortic and pulmonary ICVS are obvious and are distinct from the myocardial wall (labelled
yellow by aSMA/cTnI dual staining) in the Tbx1+/- embryo. In contrast, only a single ICVS (arrow) is seen in the
Tbx1-/- embryo. Scale bar: A = 150 mm, B-F = 100 mm.
DOI: https://doi.org/10.7554/eLife.34110.020
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Figure 9. Summary of lineage contributions to the aortic and pulmonary valve leaflets. (A–C) Cartoon showing the development of the ICVS and A/P
valve leaflets in frontal (A–C) and transverse (A’–C’) orientation from E10.5-E12.5, superimposed with the contributions from each lineage of cells.
Arrows point to the ICVS except in A’ where these cannot be seen (as they are found in the inferior and superior walls) and the arrows point to the
distal additions of SHF cells to the lateral walls. Dotted lines in A’-C’ illustrate the plane of section shown in A-C. The ICVS appear as swellings within
the outer wall of the distal outflow tract at E10.5, expand by E11.5 and discrete from the wall by E12.5, resembling the other valve leaflet primordia. (G)
Cartoon summary of the contributions of NCC, EDC and the population derived directly from the SHF to the valve leaflet primordia in the normal
embryo at E12.5. A – anterior leaflet, Ao – aorta, AoNC – aortic non-coronary (posterior) leaflet, EC – endocardial cushion, ICVS – intercalated valve
swelling, L- left leaflet, Pu – pulmonary, R – right leaflet.
DOI: https://doi.org/10.7554/eLife.34110.021
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As the ICVS mature, they switch on valve leaflet markers such as Sox9 and Versican, without utilising
EndMT as a mechanism or expressing typical mesenchymal markers. Ultimately, however, they
appear indistinguishable from the valve leaflets derived from the main outflow cushions. Specifically,
we find no evidence of trans-differentiation of either cardiomyocytes or SMC to the interstitial cells
within the ICVS, the concomitant reduction of Isl1 and increase in Sox9 protein levels within the ICVS
instead indicating a mechanism of direct differentiation of SHF progenitors into valve cells.
These studies show that three lineages make significant contributions to the arterial valve leaflets;
NCC, EDC and a novel population of SHF progenitors cells that transiently activate the Tnnt2-Cre
driver, but differentiate directly into valve interstitial cells without passing through the endocardium
nor myocardial lineages. This novel population makes the major contribution to the anterior and pos-
terior leaflets derived from the ICVS, and also significant contributions to the left and right leaflets,
derived from the main cushions (Figure 9). Although a technical limitation of these Cre-based stud-
ies is the inability to track both SHF and NCC lineages concomitantly, the absolute numbers of cells
counted, and the proportions of each, suggest that any other lineages can only comprise a minor
component (Figure 9). Previous studies have suggested that the possibility of trans-differentiation of
cardiomyocytes in the distal outflow (Ya et al., 1998). These studies were performed before knowl-
edge of the SHF and the now accepted concept that cells are added to the distal poles of the out-
flow tract. Our data strongly argue against trans-differentiation as a mechanism for formation of the
ICVS as although the Tnnt2-Cre+ cells activated the cTnT promoter, we never saw co-expression of
cardiomyocyte markers in the forming ICVS and could identify a few Tnnt2-Cre+/cTnI- cells even at
E9.5, before the ICVS form. As well as making the major contribution to the forming ICVS, these
Tnnt2-Cre+ lineage cells contribute cells to the postnatal valve leaflets although detailed phenotyp-
ing and analysis of the fate of these cells is beyond the scope of this manuscript.
Cre lineage tracing identifies cells and their descendants that currently, or have ever, expressed
the promoter/enhancer element used to drive Cre protein-based recombination of a reporter gene.
It is evident from this study that to interpret such data it is essential to track protein expression of
the Cre-driven promoter product. In the original description of the Tnnt2-Cre driver (Jiao et al.,
2003), it was stated that the rat cTnT promoter construct drove cardiomyocyte-specific expression
up to E10.5, but its expression pattern later in gestation was not described. It has also been
reported that cTnT is expressed in some SMC and can modulate their contraction (Wang et al.,
2001; Kajioka et al., 2012). From data presented here it is clear that Tnnt2-Cre labels arterial SMC,
as well as the ICVS. However, as we could not find evidence of cTnT protein expression in these lat-
ter cell types, even when we looked at the earliest stages, it is likely that transient activation of the
promoter occurred in undifferentiated, potentially multipotent, SHF progenitors within the distal
outflow. Analysis of this phenomenon in relation to the SMC is the subject of further study in our lab-
oratory. With respect to the ICVS, rather than becoming cardiomyocytes, Tnnt2-Cre labeled cells
activated Sox9 expression and differentiated to valve interstitial cells, although this occurred at
E11.5, approximately a day later than the more proximal cells within the wall differentiated to
cardiomyocytes.
Our data are generally in agreement with and build on the data of Sizarov et al (Sizarov et al.,
2012). However, these authors did not observe Sox9 staining within the cells of the ICVS of approxi-
mately stage-matched human embryos, although they did see Isl1 labelling. They also suggested
that the ‘columns’ they described were mesenchymal, although our data show that, at least in the
early stages, they are epithelial. Moreover, we did not see expression of classical mesenchymal
markers such as N-cadherin, aSMA and Fsp1, although the ICVS did express elastin, which is found
in mature valve leaflets. The differences between these studies are unclear, but it may be that they
reflect the transient expression of some of these markers and/or slight differences in staging and
maturation of the ICVS between mouse and human. The delay in differentiation of cells within the
ICVS may at least partially explain the activation of the Tnnt2 promoter in these cells, as they may be
poised, but stalled, for differentiation. The presence of Tnnt2-Cre+ lineage cells in the ICVS of the
mouse may be a valuable tool to investigate other genes involved in ICVS development, as it allows
deletion in the directly-differentiating SHF population in the ICVS, without affecting NCC or EDC.
For example, Mib1 is a ubiquitin ligase required in signalling cells for Jag activity. Here, and in a pre-
vious publication (Captur et al., 2016), arterial valve defects were observed in Mib1;Tnnt2-Cre
mutants, although initially the reason for this was unclear. Our data suggest that these defects likely
arise because Tnnt2-Cre is activated in the valve primordia, deleting Mib1 and thus inactivating
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Jag1/Jag2-Notch signalling. This prevents the ICVS, and to a lesser extent the main cushions, from
forming properly thus resulting in abnormal leaflets in the mutant embryos.
EndMT is a crucial process for typical endocardial cushions, but not for ICVS, where the major
process is development from SHF cells that directly differentiate into valve interstitial cells in situ. In
contrast, there is minor deposition of ECM and Sox9+ cells in the sub-endothelial compartment of
the forming ICVS, indicative of a small contribution by EndMT to the ICVS in this region. Notch1
together with Dll4, plays a critical early role during EndMT and Notch signalling is known to be vital
for normal development of the main endocardial cushions. Deletion of both Notch1 and Dll4
(Limbourg et al., 2005), result in the early death of the embryos, by E10.5, precluding examination
for ICVS formation and thus making it difficult to exclude EndMT from a crucial role in formation of
the ICVS. However, evidence from the knockout of Brg1 in endothelium using Nfatc1-Cre
(Akerberg et al., 2015) provides evidence that ICVS are not dependent on EndMT as both anterior
and posterior arterial valves leaflets appeared well formed in this mutant.
Our mouse data, in keeping with those of Sizarov who studied human embryos (Sizarov et al.,
2012), suggest that the ICVS form as expansions of compacted cells within the wall of the distal
OFT from cells in continuity with the epithelial SHF. These condensations form at the proximal extent
of the ‘fishmouth’ of non-myocardial distal outflow wall (Anderson et al., 2012) as seen in
Figure 1O, likely reflecting the asymmetrical addition of SHF cells and the rotation of the outflow
wall (Scherptong et al., 2012; Bajolle et al., 2006). These cell condensations then separate from
the surrounding wall, forming discrete structures that then undergo differentiation to typical valve
cells. Thus, these ICVS cells appear to share an origin and be juxtaposed with the myocardial compo-
nent of the outflow wall. Indeed, both the myocardial and the ICVS cells are Tnnt2-Cre+ suggesting
a close relationship between the two populations. It is of note that Jag1 was abundant in the ICVS,
which do not utilise EndMT/EMT, and is also abundantly expressed in the outflow tract myocardium.
Although Jag1 is also essential for valve development, its role in EndMT is controversial, with some
authors suggesting it is important (Wang et al., 2013), but others suggesting it is not required for
EndMT but plays a later role in the remodelling phases of the main cushion-derived heart valves
(MacGrogan et al., 2016). From our data, and those of others (High et al., 2007), it seems likely
that it is Notch1 and/or Notch2 that is the main Notch receptor in the ICVS. Notch1ICD was found
in the distal outflow wall and the ICVS, but only transiently, and it was largely down-regulated by
E11.5. Notch2 was expressed throughout the ICVS and until E11.5, although as we could not obtain
an antibody for the active form of this protein, we cannot be sure that signalling was underway
throughout this period. This transient expression within the ICVS is in contrast to the endocardium
overlying the main cushions, where both Notch1 and Notch2 were maintained until E12.5 and
beyond (Del Monte et al., 2007). Notch signalling has been shown to be important for the differen-
tiation of cardiac progenitor cells, with its down-regulation crucial for differentiation to cardiomyo-
cytes (Nemir et al., 2006; Kwon et al., 2009) and for activation of Sox9 in cartilage precursors
(Mead and Yutzey, 2009). Thus, the presence and then subsequent removal of Notch1 signalling
may be essential in the ICVS for their differentiation to valve interstitial cells. In support of the idea
that Notch-Jag signalling is playing an important role in the development of the ICVS, the deletion
of Jag1/Jag2 using Tnnt2-Cre resulted in abnormal development of the arterial valve leaflets in 9/11
double mutants examined, including BAV without raphe. Specifically, in 5/11 cases the phenotype
was absence or hypoplasia of the non-coronary leaflet that is derived from the ICVS. Although the
Jag1/2;Tnnt2-Cre mice have a range of defects affecting the ventricular myocardium
(D’Amato et al., 2016), and so valve defects secondary to the ventricular defects cannot strictly be
ruled out, it seems more likely that the reduction/loss of the non-coronary leaflet results from the
deletion of Jag expression specifically in the ICVS. The redundancy of Jag1 and Jag2 is intriguing
and is reminiscent of ventricular wall development (D’Amato et al., 2016). Although Jag1 was
expressed in the core of the ICVS, Jag2 was restricted to the adluminal cells, close to N1ICD-
expressing cells, suggesting that there may be some ligand-specific functional specialization. Further
studies will be necessary to delineate these likely complex interactions.
The Vangl2;Isl1-Cre and Tbx1 mutant mouse lines, both of which have abnormalities associated
with limited addition of SHF cells to the outflow, have abnormal valve leaflets that result from failure
to form or mature the ICVS; a mechanism that has not previously been described. In the Vangl2
mutant, premature differentiation of SHF to cardiomyocytes, as occurs earlier in the aortic sac
(Ramsbottom et al., 2014), may reduce the availability of SHF-derived cells to form Sox9+ valve
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interstitial cells and may underlie the reduction in the size of the ICVS and ultimately lead to BAV.
The reduction in Notch1ICD and Jag1 in 2 of 3 Vangl2f/f;Isl1-Cre embryos suggests that Notch sig-
nalling may be playing a role in this process and be regulated by Vangl2, either directly or indirectly.
Notably, the defects were more common in the aortic valve (as they are in the Notch signalling path-
way mutants) and although the reasons for this are uncertain, aortic (but never pulmonary) hypopla-
sia is common in the naturally occurring Vangl2 mutant, loop-tail (Henderson et al., 2001). This
suggests that it is the SHF that contributes to the aorta that is preferentially affected in this mutant.
Premature loss of progenitor phenotype and differentiation of cardiomyocytes leading to a marked
reduction of SHF-derived subpulmonary myocardium has been reported in the Tbx1 mutant mouse
(Vitelli et al., 2010). In addition, absence of the anterior leaflet of the pulmonary valve (derived
from the pulmonary ICVS) has also been reported (The´veniau-Ruissy et al., 2008). Our analyses
extend these data to show that a discrete pulmonary ICVS is never formed in the Tbx1-/- and high-
lights similarities in the ICVS phenotype between these and the Vangl2;Isl1-Cre mutants. Moreover,
the role of both Vangl2 and Tbx1 in regulating the epithelial properties of the SHF
(Ramsbottom et al., 2014; Francou et al., 2014), which form the myocardium and also appear to
form the ICVS, suggests that the epithelial phenotype of these cells, at least at early stages of their
development, may be crucial. Indeed, it raises the possibility that there is an intrinsic relationship
between the loss of epithelial properties of the wall and differentiation of the cells within it to cardio-
myocytes. These differences between the affected valve observed between Vangl2 and Tbx1
mutants likely reflect inherent differences in the patterning of the outflow tract, further reflecting
subdomains within the SHF (Vitelli et al., 2010; Scherptong et al., 2012). BAV has been described
in a number of mouse mutants. Notably, in several cases (including following knockout of Alk2, a
BMP receptor (Thomas et al., 2012), and Slit/Robo (Mommersteeg et al., 2015) signalling) the
anterior/non-coronary leaflets specifically failed to form properly. This, therefore may be a common
mechanism underlying BAV (without raphe) formation, at least in mice, and may occur when there is
disruption of the SHF as we see in the Vangl2;Isl1-Cre and Tbx1 mutants. Raphe are infrequently
described in mouse mutants with BAV, although this may be because most mouse mutants are
described during fetal life when the leaflets remain unsculpted and thus before a true raphe would
be apparent. Although it is not possible to demonstrate the mechanisms of arterial valve develop-
ment using human embryos it is important to note that at comparable stages of development the
appearances of human and mouse valve primordia are very similar and importantly, the expression
pattern of Isl1, marking SHF progenitors, is identical. Together our data suggest that loss of SHF
progenitors, either because of a failure of their formation or their premature differentiation, may be
a common cause of BAV and can explain the common association between this and other intra-car-
diac heart malformations. As such, BAV formed in this way may link to the subtype of BAV patterns
without raphe, as occurs in 5–10% of BAV cases (Sievers and Schmidtke, 2007; Buchner et al.,
2010). It will be important to analyse genomic data from patients with this BAV phenotype, search-
ing in particular in SHF and Jag-Notch pathways.
Our murine and human data show differences between the structure of the aortic and pulmonary
ICVS as they develop, that could have relevance to the common incidence of BAV compared to
bicuspid pulmonary valve. The aortic ICVS develops more proximally and is not surrounded by a
myocardial cuff as it develops, compared with the pulmonary ICVS, which is more distal and is
completely surrounded by cardiomyocytes. These differences have also been reported recently in a
histological examination of human embryos (Milos et al., 2017). Moreover, the pulmonary ICVS has
a lesser contribution from NCC than does the aortic, and based on the differences we see between
Vangl2 and Tbx1 mutants, may have different genetic regulation. The ICVS also express tropoelastin
during their formation, whereas the main cushions do not, suggesting that these differences in cell
lineage between the forming leaflets are reflected by expression of specific proteins. These differen-
ces are likely to have morphogenetic impacts on the developing aortic and pulmonary ICVS, which
might reflect in their differential predisposition to pathology. Although bicuspid pulmonary valve is
rare as an isolated finding in humans, it is common in association with tetralogy of Fallot
(Chacko et al., 2017). Thus, defects in the SHF that result in failure to develop one or other ICVS
might be relevant to a high proportion of human valve abnormalities.
Eley et al. eLife 2018;7:e34110. DOI: https://doi.org/10.7554/eLife.34110 19 of 27
Research article Developmental Biology
Materials and methods
Key resources table
Reagent type
(species) or resource Designation Source or reference Identifiers Additional information
Genetic reagent
(Mus musculus)
Mef2c-AHF-Cre PMID: 16188249
Genetic reagent
(Mus musculus)
Wnt1-Cre PMID: 9843687
Genetic reagent
(Mus musculus)
Tek-Cre PMID: 11161575
Genetic reagent
(Mus musculus)
Wt1-ERT-Cre PMID: 18568026
Genetic reagent
(Mus musculus)
Tnnt2-Cre PMID: 12975322
Genetic reagent
(Mus musculus)
ROSA-Stop-eYFP PMID: 11299042
Genetic reagent
(Mus musculus)
Isl1-Cre PMID: 14667410
Genetic reagent
(Mus musculus)
Vangl2 flox PMID: 25521757
Genetic reagent
(Mus musculus)
mTmG PMID: 17868096
Genetic reagent
(Mus musculus)
Tbx1 null PMID: 11242110
Genetic reagent
(Mus musculus)
Jag1 flox PMID: 15550486
Genetic reagent
(Mus musculus)
Jag2 flox PMID: 20533406
Genetic reagent
(Mus musculus)
Mib1 flox PMID: 18043734
Biological
sample(Homo sapien)
Embryo sections
CS14, 16, 21
HDBR;
PMID: 26395135
Antibody Anti-GFP Abcam ab13970 1/150
Antibody Sox9 Abcam ab185230 1/150
Antibody Versican Abcam ab1032 1/150
Antibody Collagen I Abcam ab21286 1/150
Antibody Alpha smooth
muscle actin
Abcam ab5228 and ab5694 1/150
Antibody SM22 alpha Abcam ab14106 1/150
Antibody Cardiac troponin T Abcam ab8295 1/150
Antibody E-cadherin Abcam ab15148 1/150
Antibody Notch2 Abcam ab8926 1/150
Antibody Cre recombinase NEB 15036 1/150
Antibody Cardiac troponin I HyTest 4T21/2 1/150
Antibody Laminin Sigma L9393 1/150
Antibody CS56 Sigma C8035 1/150
Antibody Isl1 Developmental Studies
Hybridoma Bank
39.4D5 and 40.2D6 1/150
Antibody N-cadherin BD Transduction
Laboratories
610920 1/150
Antibody Notch1ICD Cell Signalling 4147 1/150
Antibody Jagged 1 Cell Signalling 2620 1/150
Continued on next page
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Continued
Reagent type
(species) or resource Designation Source or reference Identifiers Additional information
Antibody Jagged 2 BioRad MCA5708GA 1/150
Sequence
-based reagent
Snail cDNA probe
for in situ hybridisation
PMID: 9671584
Sequence
-based reagent
Slug cDNA probe
for in situ hybridisation
this paper sequences provided
in text
Mouse strains and histological analysis
CD1 mice were used to observe normal histology of the developing heart. Mef2c-AHF-Cre
(Verzi et al., 2005), Wnt1-Cre (Danielian et al., 1998), Tek-Cre (Kisanuki et al., 2001), Wt1-ERT-
Cre (Zhou et al., 2008) and Tnnt2-Cre (Jiao et al., 2003), intercrossed with the ROSA-Stop-eYFP
(Srinivas et al., 2001) or mTmG (Muzumdar et al., 2007), were used to follow cells of the required
lineage/cell type. As both marker genes are targeted into the Rosa26 locus and there is no sugges-
tion of differences in recombination in response to Cre between these two lines (Liu et al., 2013),
the two lines were used interchangeably. Vangl2flox;Isl1-Cre (Ramsbottom et al., 2014), Tbx1
(Jerome and Papaioannou, 2001), Jag1flox;Jag2flox;Tnnt2-Cre (D’Amato et al., 2016), and Mib1flox;
Tnnt2-Cre (Garg et al., 2005) were used and genotyped as described previously. Timed matings
were carried out overnight and the presence of a copulation plug was designated embryonic day (E)
0.5. All mice were maintained on a C57Bl/6 background, backcrossed for three generations, then
maintained by brother-sister matings. Littermate controls were used where appropriate. Each experi-
ment was carried out in, at minimal, triplicate. Cre expression was induced in the Wt1-ERT-Cre line
by Tamoxifen injection. Pregnant females were injected intraperitoneally with 100 ml of tamoxifen
(10 mg/ml) dissolved in ethanol and peanut oil on three consecutive days (E9.5, E10.5, E11.5).
Embryos were then collected at E12.5. Mice were maintained according to the Animals (Scientific
Procedures) Act 1986, United Kingdom, under project license PPL 30/3876. All experiments were
approved by the Newcastle University Ethical Review Panel.
Embryos were harvested at different developmental stages, rinsed in ice-cold phosphate-buffered
saline (PBS) and fixed in 4% paraformaldehyde at 4˚C, the duration of which depended on the age
of the embryo (4 hr for E9.5–10.5, overnight for E11.5 and 48 hr for E12.5 to E15.5), before paraffin
embedding. Embryos were embedded in either a transverse, frontal or sagittal orientation. For each
analysis carried out using embryos, a minimum of 3 embryos for each developmental stage and sec-
tion orientation were used (biological replicates). Stage matching was carried out based on somite
counting and other external features such as limb maturity. The analyses were carried out as sepa-
rate experiments and a minimum of 5–10 sections (technical replicates) were analysed for consis-
tency. For basic histological analysis, paraffin-embedded embryos were sectioned and stained with
haemotoxylin and eosin following standard protocols.
Human embryos
The human embryonic and fetal material was provided by the Joint MRC/Wellcome Trust (grant #
099175/Z/12/Z) Human Developmental Biology Resource (www.hdbr.org [Gerrelli et al., 2015]). For
basic histological analysis, paraffin-embedded embryos were sectioned and stained with haemotoxy-
lin and eosin following standard protocols.
Three-dimensional reconstruction
Serial sections were photographed from control and mutant embryos at E10.5 and E11.5. The sec-
tions were aligned and three dimensional reconstructions were carried out using Amira 4.0 accord-
ing to standard protocols (Soufan et al., 2003).
Immunohistochemistry/Immunofluorescence
Methodology has been published previously (Phillips et al., 2007). Sections were cut from paraffin
embedded embryos at 8 mm using a rotary microtome (Leica). Slides were de-waxed with Histoclear
(National Diagnostics) and rehydrated through a series of ethanol washes. For immunohistochemistry
for lineage tracing purposes, endogenous peroxidases were inhibited by treating slides with 3%
Eley et al. eLife 2018;7:e34110. DOI: https://doi.org/10.7554/eLife.34110 21 of 27
Research article Developmental Biology
H2O2 for 5 min. Following washes in PBS, antigen retrieval was performed by boiling slides in citrate
buffer (0.01 mol/L) pH 6.3 for 5 min. Samples were blocked in 10% FCS and then incubated over-
night at 4˚C with the primary antibody GFP (Abcam) diluted in 2% FCS. Samples were then incu-
bated with an anti-chicken biotinylated secondary antibody (Dako) for 1 hr, then with AB complex
(Vector labs) for 30 min then stained with DAB and mounted using Histomount. This amplification
step ensured maximal detection of antigen. Bright field images were captured using the Zeiss Axio-
plan. For immunofluorescence, following washes in PBS, antigen retrieval was performed by boiling
slides in citrate buffer (0.01 mol/L) pH 6.3 for 5 min. Sections were blocked in 10% FCS and then
incubated overnight at 4˚C with the primary antibodies (see key resources table) diluted in 2% FCS.
After washing, sections were incubated at room temperature for one hour, with secondary antibod-
ies conjugated to either Alexa 488 or Alexa 594 (Life Technologies). Fluorescent slides were then
mounted with Vectashield Mounting medium with DAPI (Vector Labs). Each experiment was carried
out in triplicate using separate embryos (>3) and imaging multiple sections of the structure of inter-
est (>5). Immunofluorescence images were collected with using a Zeiss Axioimager Z1 fluorescence
microscope equipped with Zeiss Apotome 2 (Zeiss, Germany). Acquired images were processed
with AxioVision Rel 4.9 software.
cDNA probes and in situ hybridisation
Methodology was adapted from (Smart et al., 2002). Digoxigenin (DIG)-labeled RNA antisense
probes corresponding to the protein coding regions of Slug (EF450456.1; Forward primer:
TTTCAACGCCTCCAAGAAGC; Reverse primer: TAATACGACTCACTATAGGGGCAGCCAGACTCC
TCATGTT) and Snail (NM_001032543; [Sefton et al., 1998]) were synthesized by T7 RNA polymer-
ase (MAXIScript, Ambion) and in vitro transcription (pGEM_T easy, Promega), respectively. The slide
in situ hybridization was performed using 10 um paraffin-embedded sections of E10.5 and E11.5
mouse embryos. Slides were de-waxed with Histoclear (National Diagnostics) and rehydrated with
ethanol series washes. Slides were then fixed in 4% DEPC-PFA for 20 min at room temperature prior
to the treatment with proteinase K (10 mg/mL) for 10 min at 37˚C. Post-fixation by 4% DEPC-PFA
was performed at room temperature for 5 min. Slides were then processed to the acetylation reac-
tion for 10 min in solution containing 100 mM Triethanolamine, 40 mM Hydrochloric acid and 250
mM Acetic Anhydride. After that, pre-hybridization was performed for 2 hr at 68˚C using hybridiza-
tion buffer (50% formamide, 5x SSC (pH6), 200 mg/mL T-RNA, 100 mg/mL Heparin, 0.1% tween-20);
hybridization was carried out for 16 hr using the same buffer with RNA probes. Following a series of
washes, slides were blocked in 2% MABT (maleic acid buffer containing Tween 20) blocking solution
(Roche) for 2 hr and incubated with anti-digoxigenin-AP, fab fragments (Roche) overnight at 4˚C.
Slides were then developed in NBT/BCIP solution for 18–36 hr at room temperature and the reaction
terminated through incubation in 100% methanol for 5 min. Counterstaining with 1% eosin for 5 min
was performed, followed by dehydration with washes in a serial ethanol dilutions (30–60 s per wash),
incubation in Histoclear twice for 10 min, and finally mounting slides with Histomount (Agar scien-
tific). Each experiment was carried out in triplicate using separate embryos (>3) and imaging multiple
sections of the structure of interest (>5).
Cell counts and statistical analysis
For quantification of Mef2c-AHF-Cre in the E12.5 arterial valve leaflet primordia, labelled and unla-
belled cells were counted by a single observer (with checks for accuracy from an independent
observer) from each of the six discrete primordia. In each case, three representative sections from
three different embryos were counted. All sections were 8 mm (as were comparable data sets in
Phillips et al., 2013). Chi squared analysis was used to show that the proportion of Mef2c-AHF-Cre
lineage cells between the different arterial valve primordia were significantly different. Pairwise chi-
squared comparison between the primordia, with Bonferroni correction for multiple testing, con-
firmed that the aortic non-coronary primordium was statistically different from all other primordia.
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